Zydus Pharmaceuticals (USA) Inc recalls Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadoda…
- Recall date
- July 2, 2024
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Recall number
- D-0595-2024
- FDA classification
- Class III
- Brand / firm
- Zydus Pharmaceuticals (USA) Inc
- Sold / distributed
- Nationwide in the USA and Puerto Rico
Why it was recalled
Cross contamination with other products
Class III means the product violates regulations but is not likely to cause harm.
What was recalled
Micafungin for injection, USP, 100 mg/vial, Single-Dose Vial, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Vadodara, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 70710-1725-01 (vial), NDC 70710-1725-06 (outer box).
Get recall alerts
Free email alert whenever Zydus Pharmaceuticals (USA) Inc has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Zydus Pharmaceuticals (USA) Inc